Skip to main content

Table 2 Characteristics of the products used during participants’ most recent co-use experience

From: Simultaneous cannabis and psychedelic use among festival and concert attendees in Colorado: characterizing enhancement and adverse reactions using mixed methods

Characteristics

N

%

M

SD

Min

Max

Psychedelic(s) used

 LSD

26

41.3

    

 Psilocybin

32

50.8

    

 DMT

3

4.8

    

 Mescaline

2

3.2

    

 MDMA

17

27.0

    

 Ketamine

11

17.5

    

Cannabis product(s) used

 Flower

50

79.4

    

 Concentrates

32

50.8

    

 Edibles

14

22.2

    

Flower characteristics

 Quantity (grams)

  

3.76

3.89

0.2

14

 Within-session frequency (times used)

  

6.02

5.95

1

21

 THC content

  0–4%

2

4.0

    

  5–9%

1

2.0

    

  10–14%

1

2.0

    

  15–19%

7

14.0

    

  20–24%

12

24.0

    

  25–30%

9

18.0

    

  Greater than 30%

3

6.0

    

  Unsure

15

30.0

    

Concentrate Characteristics

 Dab quantity (# of dabs)

  

4.06

4.67

1

21

 Cartridge quantity (# of hits)

  

11.21

7.90

2

21

 Dab within-session frequency (times used)

  

3.67

2.94

1

11

 Cartridge within-session frequency (times used)

  

8.67

6.89

1

21

 Dab THC content

  Less than 50%

3

15.0

    

  50–59%

1

5.0

    

  60–69%

1

5.0

    

  70–79%

8

40.0

    

  80–90%

1

5.0

    

  Greater than 90%

0

0.0

    

  Unsure

6

30.0

    

 Cartridge THC content

  Less than 50%

4

18.2

    

  50–59%

2

9.1

    

  60–69%

2

9.1

    

  70–79%

2

9.1

    

  80–90%

7

31.8

    

  Greater than 90%

0

0.0

    

  Unsure

5

22.7

    

Edible Characteristics

  Edibles within-session frequency (times used

  

1.73

1.39

1

6

  Edibles THC content (milligrams)

  

70.00

69.85

5

200